Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 11, 2026
Bending Spoons (BSP) Stock Drops -19% in 30 Days After Earnings Beat

Bending Spoons (BSP) Stock Drops -19% in 30 Days After Earnings Beat

Key Takeaways

  • BSP shares have declined roughly 19% over the last 30 days, pulling back from a closing price near $48.98 in mid-August to about $39.67 in early September.
  • The slide followed a second-quarter 2026 earnings report that beat estimates but revealed slowing organic revenue growth and elevated leverage, triggering an approximately 18% single-day decline.
  • Bending Spoons listed on the Nasdaq on July 1, 2026, at $29.00 per share and remains comfortably above its IPO price despite the recent retreat.
  • Valuation concerns, with a price-to-sales multiple well above software peers, and a cooling technology tape weighed on investor sentiment.
  • A newly announced $1.355 billion agreement to acquire Miro helped the stock stabilize and bounce from its recent lows in early September.

Bending Spoons' Business Model and Market Position

Bending Spoons S.p.A. is an Italian technology company founded in 2013 and headquartered in Milan. Rather than building products from scratch, the company acquires established digital businesses with proven market fit and seeks to improve their profitability through operational efficiency, revenue growth, and cost discipline. This acquisition-and-optimization model is built around a centralized platform the company calls the Spoon Engine.

Its portfolio spans well-known consumer and creator tools, including AOL, Evernote, WeTransfer, Vimeo, Meetup, Remini, and Splice, among others. The company serves hundreds of millions of monthly active users and millions of paying subscribers, with the large majority of its revenue derived from recurring subscriptions. Bending Spoons completed its initial public offering on the Nasdaq Global Select Market on July 1, 2026, raising approximately $1.68 billion at an offering price of $29.00 per share. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

BSP Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, BSP has moved sharply lower. From a closing price of $48.98 on August 12, 2026, the stock declined to $39.67 by September 10, 2026, a drop of approximately 19%. The pullback was punctuated by an especially steep sell-off around the company's second-quarter earnings release in mid-August.

The broader quarterly picture tells a more nuanced story. Because Bending Spoons only began trading on July 1, 2026, its quarter-to-date history is essentially its entire public history. Shares surged roughly 40% on their first day, closing at $40.50, and later climbed to a closing peak of $53.44 on August 11, with an intraday high of $58.94. Even after the recent decline, the stock sits about 37% above its $29.00 IPO price, though it has retraced roughly 26% from its mid-August closing peak.

What Drove BSP Stock Price in the Last 30 Days

The dominant catalyst for the 30-day decline was the company's second-quarter 2026 earnings report, released on August 13. Bending Spoons delivered revenue of $704 million, up 126% year over year, and adjusted earnings per share of $0.46, well above the $0.27 consensus estimate. Despite the beat, shares fell about 18% in the session as investors focused on slowing organic revenue growth, which decelerated to roughly 3% from 6% in the prior quarter, and on the company's balance sheet, where net debt reached approximately $4.09 billion with a leverage ratio of about 2.4 times.

Valuation also played a meaningful role. At recent levels, Bending Spoons has traded at a price-to-sales multiple of roughly 13 to 14 times, materially above the broader software industry average and its closer peer set. As the initial post-IPO enthusiasm faded, investors reassessed whether the acquisition-driven model justified that premium. A broader cooling in technology and AI-related sentiment during the period compounded the pressure.

Toward the end of the window, sentiment improved. On September 10, the company announced a definitive agreement to acquire the digital collaboration platform Miro in an all-cash transaction valued at $1.355 billion in enterprise value, and shares rose in response, helping to stabilize the recent downtrend.

What Drove BSP Stock Performance Over the Last Quarter

The quarter's narrative centers on a high-profile debut followed by a re-rating. Bending Spoons' IPO drew strong institutional demand, and the stock nearly doubled from its offering price within its first days of trading, lifting its market capitalization above $25 billion. That early surge was fueled by enthusiasm for its serial-acquisition playbook and its portfolio of recognizable digital brands.

As the quarter progressed, the focus shifted from growth optics to balance-sheet and execution risk. The company completed a $759 million acquisition of Tractive, agreed to acquire Airtable for approximately $1.285 billion, and later announced the Miro transaction, underscoring an aggressive deal pipeline. At the same time, investors grew more sensitive to the debt used to fund that growth, the slowing pace of organic expansion, and a premium valuation that left limited room for error. The result was a quarter that began with a sharp rally and ended with a meaningful correction.

BSP Stock Forecast Drivers: What Investors Should Watch Next

Several factors will shape BSP's trajectory in the months ahead. The closing and integration of the Miro and Airtable acquisitions are central, as investors will watch whether the company can convert these purchases into durable, margin-accretive growth without overextending its balance sheet. The pace of organic revenue growth, separate from acquisition-driven gains, remains a key metric after its recent slowdown.

Leverage and financing costs are another focus, given the company's substantial net debt and its sensitivity to interest-rate conditions. Bending Spoons' next earnings report is expected in early December, and updated revenue guidance will be closely scrutinized. Analysts maintain a broadly constructive view, with a consensus Buy rating and an average 12-month price target near $48, though that implies a wider gap between expectations and execution as the acquisition pipeline expands. Broader technology-sector sentiment will also continue to influence near-term price action. From what I see, the acquisition pace remains the most important variable to monitor.

Exploring Tickeron’s Trending AI Robots

As someone who follows momentum across a wide range of names, I find Tickeron’s Trending AI Robots page helpful for spotting which AI-powered strategies are drawing the most attention right now. It curates top-performing bots across different approaches and timeframes, giving a quick way to explore ideas that align with current market conditions without having to sift through everything manually.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BSP

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Datadog (NASDAQ:DDOG), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 9.9B. The market cap for tickers in the group ranges from 39 to 244.09B. SAPGF holds the highest valuation in this group at 244.09B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 11%. RPGL experienced the highest price growth at 180%, while WCT experienced the biggest fall at -87%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -45%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Industry
N/A
Address
Via Nino Bonnet 10
Phone
+39 281284093
Employees
2284
Web
https://www.bendingspoons.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.